Notch and PI3K: How is the road traveled?

Blood

Volumn 120, Issue 7, 2012, Pages 1349-1350

  Bailis, Will ^a   Pear, Warren S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 7 RECEPTOR; NOTCH RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; SOMATOMEDIN C RECEPTOR; TRANSCRIPTION FACTOR HES 1;

ACUTE LYMPHOCYTIC LEUKEMIA; CANCER CELL; CANCER CELL CULTURE; CELL EXPANSION; CELL GROWTH; CELL MATURATION; CELL SURVIVAL; CELL TRANSFORMATION; DROSOPHILA; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; LEUKEMOGENESIS; LOSS OF FUNCTION MUTATION; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T CELL LEUKEMIA; T LYMPHOCYTE; THYMOCYTE;

EID: 84865187020     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-06-435099     Document Type: Note

References (10)

1. Wong GW, Knowles GC, Mak TW, Ferrando AA, Zúñiga- Pflücker JC. HES1 opposes a PTEN-dependent check on survival, differentiation, and proliferation of TCRbeta-selected mouse thymocytes. Blood. 2012;120(7): 1439-1448.
2. JuntillaMM,Koretzky GA. Critical roles of the PI3K/ Akt signaling pathway inTcell development. Immunol Lett. 2008;116(2):104-110.
3. Palomero T, Sulis ML, Cortina M, et al. Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia. Nat Med. 2007;13(10):1203-1210. (Pubitemid 47530629)
4. González-Garcia S, Garcia-Peydro M, Martin-Gayo E, et al. CSL-MAML-dependent Notch1 signaling con-trolsTlineage- specific IL-7R{alpha} gene expression in early human thymopoiesis and leukemia. J Exp Med. 2009; 206(4):779-791.
5. Medyouf H, Gusscott S, Wang H, et al. High-level IGF1R expression is required for leukemia-initiating cell activity in T-ALL and is supported by Notch signaling. J Exp Med. 2011;208(9):1809-1822.
6. Chan SM, Weng AP, Tibshirani R, Aster JC, Utz PJ. Notch signals positively regulate activity of themTOR pathway in T-cell acute lymphoblastic leukemia. Blood. 2007;110(1):278-286. (Pubitemid 47026845)
7. Lee K, Nam KT, Cho SH, et al. Vital roles ofmTOR complex 2 in Notch-driven thymocyte differentiation and leukemia. J Exp Med. 2012;209(4):713-728.
8. Medyouf H, Gao X, Armstrong F, et al. Acute T-cell leukemias remain dependent on Notch signaling despite PTEN and INK4A/ARF loss. Blood. 2010;115(6):1175-1184.
9. Cullion K, Draheim KM, Hermance N, et al. Targeting the Notch1 andmTORpathways in a mouseT-ALL model. Blood. 2009;113(24):6172-6181.
10. Wendorff AA, Koch U, Wunderlich FT, et al. Hes1 is a critical but context-dependent mediator of canonical Notch signaling in lymphocyte development and transformation. Immunity. 2010;33(5):671-684.